Karacsonyi, J.
Vemmou, E.
Nikolakopoulos, I. D.
Ungi, I.
Rangan, B. V.
Brilakis, E. S.
Article History
Accepted: 30 September 2020
First Online: 27 October 2020
Conflict of interest
: J. Karacsonyi, E. Vemmou, I.D. Nikolakopoulos, I. Ungi and B.V. Rangan declare that they have no competing interests. E. S. Brilakis has received consulting/speaker honoraria from Abbott Vascular, the American Heart Association (associate editor of <i>Circulation</i>), Amgen, Biotronik, Boston Scientific, the Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex, as well as research support from Regeneron and Siemens. He is a shareholder of MHI Ventures.